动物微生物组市场规模、份额和增长分析：按动物种类、产品类型、原材料、形态、应用、最终用户、通路和地区划分——2026-2033年行业预测

2024年全球动物微生物组市场价值为43亿美元，预计将从2025年的46.9亿美元成长到2033年的94.2亿美元。预测期（2026-2033年）的复合年增长率预计为9.1%。

全球动物微生物组市场专注于分析和调控家畜、水产养殖物种和伴侣动物体内的微生物群落，以改善其健康、生产力和永续性。随着人们对更安全蛋白质替代品的需求日益增长，该领域正从传统抗生素转向生物疗法，益生菌和创新定序技术能够实现精准干预，并因此备受关注。如今，企业更倾向于使用特定的微生物群落而非频谱益生菌，改善动物健康并提高农场盈利。人工智慧技术的进步进一步提升了诊断准确性，能够可靠地检测相关微生物类群，并揭示微生物组模式与临床结果之间的关联。这一发展趋势正在吸引各领域的投资和合作，推动水产养殖、宠物护理和环保畜牧业实践取得显着进展。

全球动物微生物组市场驱动因素

随着生产者积极采用以微生物组为基础的产品来改善动物健康、优化饲料转换率并增强抗病能力，全球动物微生物组市场需求激增。这种日益增长的兴趣正在推动创新，减少对传统干预措施的依赖，并为客製化益生菌、益生元和诊断技术的投资铺平道路。随着农场经营者将永续性和动物福利置于优先地位，各公司正积极拓展产品线和分销管道，以加速市场进入。动物生产力和产品品质的显着提升，促使相关人员更愿意将微生物组解决方案融入其实践，从而推动更广泛的商业性认可和市场逐步成长。

全球动物微生物组市场的限制因素

全球动物微生物组市场面临许多挑战，主要源自于区域层面复杂且不断变化的法规结构。这种监管复杂性导致製造商和开发商在产品分类、功效声明和核准流程方面存在不确定性，阻碍了市场准入和商业化进程。安全性资料和功效论证要求的差异也使全球产品推广更加复杂，需要投入更多的时间和资源来确保合规。小规模企业被迫推迟研发计画并限制其业务范围，而成熟企业则面临日益沉重的监管负担。这种监管上的不确定性最终会减缓生产商和经销商对产品的接受度，降低投资吸引力，并限制创新微生物组解决方案的上市速度。

动物微生物组市场的全球趋势

全球动物微生物组市场正日益接受精准微生物组营养。饲料和补充剂开发商正致力于开发基于微生物组的策略，以适应动物独特的肠道生态系统。这一趋势推动了原料选择和添加剂配方向特定微生物功能方向转变，从而提高饲料转换率、动物健康和产品品质。此外，市场对包含微生物分析和可操作建议的综合解决方案的需求也在不断增长，这使得营养师能够从通用饲餵方法转向有针对性的、以结果为导向的方案。这种转变不仅有利于动物福利和永续性，也代表着畜牧业营养管理向个人化方向迈进的进步。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球动物微生物组市场规模：按动物类型和复合年增长率划分（2026-2033 年）

• 宠物
• 家畜
• 水产养殖

全球动物微生物组市场规模：依产品类型及复合年增长率划分（2026-2033 年）

• 益生菌
• 益生元
• 共生
• 微生物生物质

全球动物微生物组市场规模：按来源和复合年增长率划分（2026-2033 年）

• 植物来源
• 动物源性
• 发酵

全球动物微生物组市场规模：按类型和复合年增长率划分（2026-2033 年）

• 粉末
• 液体
• 颗粒
• 其他的

全球动物微生物组市场规模：按应用和复合年增长率划分（2026-2033 年）

• 保持健康
• 疾病治疗
• 营养与补充品
• 其他的

全球动物微生物组市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 家禽养殖户
• 宠物饲主
• 动物医院
• 研究机构

全球动物微生物组市场规模：按分销管道和复合年增长率划分（2026-2033 年）

• 线上零售
• 线下零售

全球动物微生物组市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• AnimalBiome
• ProDigest
• Lallemand
• Adisseo
• Hills Pet Nutrition
• Pando Nutrition
• CanBiocin
• MiDOG
• DNA Genotek
• Animab
• BaseClear
• Novonesis
• MicroSintesis
• Eligo Bioscience
• Eubiotics
• Resistomap
• DSM-Firmenich
• Phileo
• Mootral
• Evonik

结论与建议

Global Animal Microbiome Market size was valued at USD 4.3 Billion in 2024 and is poised to grow from USD 4.69 Billion in 2025 to USD 9.42 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global animal microbiome market focuses on the analysis and manipulation of microbial communities in livestock, aquaculture species, and companion animals to enhance health, productivity, and sustainability. As the demand for safer protein alternatives rises, the sector shifts from traditional antibiotics to biological methods, highlighting probiotics and innovative sequencing techniques that allow for precise interventions. Companies are now prioritizing defined microbial consortia over broad-spectrum probiotics, resulting in improved animal health outcomes that translate into farm profitability. Advances in AI further enhance diagnostic accuracy, enabling reliable detection of relevant microbial taxa and linking microbiome patterns to clinical outcomes. This evolution attracts investment and partnerships across various sectors, fostering significant advancements in aquaculture, pet care, and environmentally conscious livestock practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Microbiome market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Microbiome Market Segments Analysis

Global animal microbiome market is segmented by animal type, product type, source, form, application, end user, distribution channel and region. Based on animal type, the market is segmented into Pets, Livestock and Aquaculture. Based on product type, the market is segmented into Probiotics, Prebiotics, Symbiotic and Microbial Biomass. Based on source, the market is segmented into Plant based, Animal Based and Fermented. Based on form, the market is segmented into Powder, Liquid, Granules and Others. Based on application, the market is segmented into Health Maintenance, Disease Treatment, Nutrition and Supplements and Others. Based on end user, the market is segmented into Poultry Farmers, Pet Owners, Veterinary Clinics and Research Institutions. Based on distribution channel, the market is segmented into Online Retail and Offline Retail. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Microbiome Market

The Global Animal Microbiome market is witnessing a surge in demand as producers worldwide increasingly embrace microbiome-based products to enhance animal health, optimize feed efficiency, and bolster disease resilience. This growing interest stimulates innovation and reduces dependence on traditional interventions, paving the way for investments in customized probiotics, prebiotics, and diagnostics. As farm managers prioritize sustainability and animal welfare, companies are actively broadening their offerings and distribution channels, promoting faster market adoption. The recognized advantages in animal performance and product quality further encourage stakeholders to adopt microbiome solutions in their management practices, leading to wider commercial acceptance and progressive market expansion.

Restraints in the Global Animal Microbiome Market

The global animal microbiome market faces significant challenges due to complex and ever-changing regulatory frameworks present across different regions. These regulatory complexities lead to uncertainty for manufacturers and developers regarding product classification, claims, and approval processes, thereby hindering market entry and commercialization efforts. Disparate requirements for safety data and efficacy demonstrations complicate the global launch of products, demanding more time and resources for compliance. Smaller companies might delay their development initiatives or limit their geographical reach, while established enterprises confront increased regulatory burdens. This ambiguity in regulations ultimately slows down the adoption of products by producers and distributors, diminishes investment appeal, and restricts the speed at which innovative microbiome solutions can be introduced to the market.

Market Trends of the Global Animal Microbiome Market

The Global Animal Microbiome market is increasingly embracing precision microbiome nutrition, where feed and supplement developers are focusing on microbiome-informed strategies tailored to the unique gut ecology of animals. This trend highlights a shift towards aligning ingredient selection and additive profiles with specific microbial functions to enhance feed efficiency, animal health, and product quality. Furthermore, there is a rising demand for integrated solutions that encompass microbial profiling and actionable recommendations, enabling nutritionists to transition from generic feeding approaches to targeted, outcome-driven programs. This evolution not only supports animal welfare and sustainability but also signifies a progressive move towards personalized nutrition in animal husbandry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Animal Microbiome Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Pets
• Livestock
• Aquaculture

Global Animal Microbiome Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Probiotics
• Prebiotics
• Symbiotic
• Microbial Biomass

Global Animal Microbiome Market Size by Source & CAGR (2026-2033)

• Market Overview
• Plant based
• Animal Based
• Fermented

Global Animal Microbiome Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Liquid
• Granules
• Others

Global Animal Microbiome Market Size by Application & CAGR (2026-2033)

• Market Overview
• Health Maintenance
• Disease Treatment
• Nutrition and Supplements
• Others

Global Animal Microbiome Market Size by End User & CAGR (2026-2033)

• Market Overview
• Poultry Farmers
• Pet Owners
• Veterinary Clinics
• Research Institutions

Global Animal Microbiome Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online Retail
• Offline Retail

Global Animal Microbiome Market Size & CAGR (2026-2033)

• North America (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AnimalBiome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProDigest
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adisseo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hills Pet Nutrition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pando Nutrition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CanBiocin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiDOG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Genotek
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animab
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BaseClear
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novonesis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroSintesis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eligo Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eubiotics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Resistomap
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phileo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mootral
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations